Fabiao Zhang

440 total citations
23 papers, 331 citations indexed

About

Fabiao Zhang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Fabiao Zhang has authored 23 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Fabiao Zhang's work include RNA modifications and cancer (7 papers), RNA Research and Splicing (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Fabiao Zhang is often cited by papers focused on RNA modifications and cancer (7 papers), RNA Research and Splicing (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Fabiao Zhang collaborates with scholars based in China, Australia and United States. Fabiao Zhang's co-authors include Aidong Wang, Zheping Fang, Beibei Lin, Caijiao Lu, Ruijie Chen, Xiaojie Wei, Binfeng Wang, Cai Lin, Yanan Zhu and Cheng Wang and has published in prestigious journals such as BioMed Research International, Cell Death and Disease and Oncotarget.

In The Last Decade

Fabiao Zhang

21 papers receiving 325 citations

Peers

Fabiao Zhang
Linli Shi China
Zongyu Li China
Xia Kang China
Jijie Hu China
Fabiao Zhang
Citations per year, relative to Fabiao Zhang Fabiao Zhang (= 1×) peers Shanshan Shi

Countries citing papers authored by Fabiao Zhang

Since Specialization
Citations

This map shows the geographic impact of Fabiao Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabiao Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabiao Zhang more than expected).

Fields of papers citing papers by Fabiao Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabiao Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabiao Zhang. The network helps show where Fabiao Zhang may publish in the future.

Co-authorship network of co-authors of Fabiao Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Fabiao Zhang. A scholar is included among the top collaborators of Fabiao Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabiao Zhang. Fabiao Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Minjie, et al.. (2025). Lasso-Based Nomogram for Predicting Early Recurrence Following Radical Resection in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 12. 539–552. 1 indexed citations
2.
Zhang, Fabiao, et al.. (2024). Transcription Factor MAZ Potentiates the Upregulated NEIL3-mediated Aerobic Glycolysis, thereby Promoting Angiogenesis in Hepatocellular Carcinoma. Current Cancer Drug Targets. 24(12). 1235–1249. 8 indexed citations
3.
Zhang, Wenlong, et al.. (2024). The m6A methyltransferase METTL5 promotes neutrophil extracellular trap network release to regulate hepatocellular carcinoma progression. Cancer Medicine. 13(7). e7165–e7165. 6 indexed citations
4.
Zhu, Yu, et al.. (2024). A nomogram model for early recurrence of HBV-related hepatocellular carcinomas after radical hepatectomy. Frontiers in Endocrinology. 15. 1374245–1374245.
5.
Zhang, Fabiao, et al.. (2024). HNRNPL Increases WSB1 mRNA Stability to Promote Proliferation and Lipid Droplets in Clear Cell Renal Cell Carcinoma. Cell Biochemistry and Biophysics. 82(3). 2019–2028. 2 indexed citations
6.
7.
Liu, Jian, Hao Shen, Shengyu Huang, et al.. (2023). Antiviral therapy inhibited HBV-reactivation and improved long-term outcomes in patients who underwent radiofrequency ablation for HBV-related hepatocellular carcinoma. World Journal of Surgical Oncology. 21(1). 42–42. 1 indexed citations
8.
Han, Zheng, Hua Chen, Juanjuan Huang, et al.. (2023). ASAP1 activates the IQGAP1/CDC42 pathway to promote tumor progression and chemotherapy resistance in gastric cancer. Cell Death and Disease. 14(2). 124–124. 15 indexed citations
9.
Wu, Zhonghan, Jingjing Zheng, Haoke Zhang, et al.. (2023). Molecular characteristics, oncogenic roles, and relevant immune and pharmacogenomic features of NEK2 in gastric cancer. International Immunopharmacology. 116. 109737–109737. 10 indexed citations
10.
Liu, Long, Fei Xiao, Jie Sun, et al.. (2023). Hepatocyte-derived extracellular vesicles miR-122-5p promotes hepatic ischemia reperfusion injury by regulating Kupffer cell polarization. International Immunopharmacology. 119. 110060–110060. 21 indexed citations
11.
Zhang, Fabiao, et al.. (2022). SNHG3 regulates NEIL3 via transcription factor E2F1 to mediate malignant proliferation of hepatocellular carcinoma. Immunogenetics. 75(1). 39–51. 13 indexed citations
12.
Fang, Zheping, et al.. (2021). Lesion human leukocyte antigen-E is associated with favourable prognosis for patients with oesophageal squamous cell carcinoma. Journal of International Medical Research. 49(10). 3619108206–3619108206. 3 indexed citations
13.
Zhang, Fabiao, et al.. (2020). MiR-125b promotes migration and invasion by targeting the vitamin D receptor in renal cell carcinoma. International Journal of Medical Sciences. 18(1). 150–156. 5 indexed citations
14.
Liu, Xinyu, et al.. (2018). Decreased expression of TRPV1 in renal cell carcinoma: association with tumor Fuhrman grades and histopathological subtypes. Cancer Management and Research. Volume 10. 1647–1655. 19 indexed citations
15.
Wang, Cheng, et al.. (2018). A clinical study of choledochoscopic holmium laser lithotripsy for multiple intrahepatic calculi within ERAS programs. Lasers in Surgery and Medicine. 51(2). 161–166. 5 indexed citations
16.
Ye, Qingsong, Yanqing Wu, Shuang Zou, et al.. (2017). Neural Stem Cells Expressing bFGF Reduce Brain Damage and Restore Sensorimotor Function after Neonatal Hypoxia-Ischemia. Cellular Physiology and Biochemistry. 45(1). 108–118. 17 indexed citations
17.
Wang, Cheng, et al.. (2017). Enhanced Recovery after Surgery Programs for Liver Resection: a Meta-analysis. Journal of Gastrointestinal Surgery. 21(3). 472–486. 49 indexed citations
19.
Fang, Zheping, Bei‐Ge Jiang, Fabiao Zhang, et al.. (2014). Rpb3 promotes hepatocellular carcinoma through its N-terminus. Oncotarget. 5(19). 9256–9268. 9 indexed citations
20.
Zhang, Fabiao, et al.. (2014). Lesion human leukocyte antigen-F expression is associated with a poor prognosis in patients with hepatocellular carcinoma. Oncology Letters. 9(1). 300–304. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026